This report aims to provide a comprehensive presentation of the global market for Infectious Disease Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Clinical Trials. This report contains market size and forecasts of Infectious Disease Clinical Trials in global, including the following market information:
Global Infectious Disease Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Infectious Disease Clinical Trials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Clinical Trials include IQVIA, LabCorp, Charles River, WuXi AppTec, Syneos Health, PPD and ICON Plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Disease Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Infectious Disease Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global Infectious Disease Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Infectious Disease Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Vaccines
Cell & Gene Therapy
Others
Global Infectious Disease Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Infectious Disease Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Infectious Disease Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IQVIA
LabCorp
Charles River
WuXi AppTec
Syneos Health
PPD
ICON Plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Disease Clinical Trials, market overview.
Chapter 2: Global Infectious Disease Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of Infectious Disease Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Disease Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Disease Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Disease Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Disease Clinical Trials Overall Market Size
2.1 Global Infectious Disease Clinical Trials Market Size: 2022 VS 2029
2.2 Global Infectious Disease Clinical Trials Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Disease Clinical Trials Players in Global Market
3.2 Top Global Infectious Disease Clinical Trials Companies Ranked by Revenue
3.3 Global Infectious Disease Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Clinical Trials Companies in Global Market, by Revenue in 2022
3.5 Global Companies Infectious Disease Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 Infectious Disease Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Disease Clinical Trials Market Size Markets, 2022 & 2029
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global Infectious Disease Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global Infectious Disease Clinical Trials Revenue, 2018-2023
4.2.2 By Type - Global Infectious Disease Clinical Trials Revenue, 2024-2029
4.2.3 By Type - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Disease Clinical Trials Market Size, 2022 & 2029
5.1.2 Vaccines
5.1.3 Cell & Gene Therapy
5.1.4 Others
5.2 By Application - Global Infectious Disease Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global Infectious Disease Clinical Trials Revenue, 2018-2023
5.2.2 By Application - Global Infectious Disease Clinical Trials Revenue, 2024-2029
5.2.3 By Application - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Infectious Disease Clinical Trials Market Size, 2022 & 2029
6.2 By Region - Global Infectious Disease Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global Infectious Disease Clinical Trials Revenue, 2018-2023
6.2.2 By Region - Global Infectious Disease Clinical Trials Revenue, 2024-2029
6.2.3 By Region - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Infectious Disease Clinical Trials Revenue, 2018-2029
6.3.2 US Infectious Disease Clinical Trials Market Size, 2018-2029
6.3.3 Canada Infectious Disease Clinical Trials Market Size, 2018-2029
6.3.4 Mexico Infectious Disease Clinical Trials Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Infectious Disease Clinical Trials Revenue, 2018-2029
6.4.2 Germany Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.3 France Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.4 U.K. Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.5 Italy Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.6 Russia Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.7 Nordic Countries Infectious Disease Clinical Trials Market Size, 2018-2029
6.4.8 Benelux Infectious Disease Clinical Trials Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Infectious Disease Clinical Trials Revenue, 2018-2029
6.5.2 China Infectious Disease Clinical Trials Market Size, 2018-2029
6.5.3 Japan Infectious Disease Clinical Trials Market Size, 2018-2029
6.5.4 South Korea Infectious Disease Clinical Trials Market Size, 2018-2029
6.5.5 Southeast Asia Infectious Disease Clinical Trials Market Size, 2018-2029
6.5.6 India Infectious Disease Clinical Trials Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Infectious Disease Clinical Trials Revenue, 2018-2029
6.6.2 Brazil Infectious Disease Clinical Trials Market Size, 2018-2029
6.6.3 Argentina Infectious Disease Clinical Trials Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Disease Clinical Trials Revenue, 2018-2029
6.7.2 Turkey Infectious Disease Clinical Trials Market Size, 2018-2029
6.7.3 Israel Infectious Disease Clinical Trials Market Size, 2018-2029
6.7.4 Saudi Arabia Infectious Disease Clinical Trials Market Size, 2018-2029
6.7.5 UAE Infectious Disease Clinical Trials Market Size, 2018-2029
7 Infectious Disease Clinical Trials Companies Profiles
7.1 IQVIA
7.1.1 IQVIA Company Summary
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Infectious Disease Clinical Trials Major Product Offerings
7.1.4 IQVIA Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.1.5 IQVIA Key News & Latest Developments
7.2 LabCorp
7.2.1 LabCorp Company Summary
7.2.2 LabCorp Business Overview
7.2.3 LabCorp Infectious Disease Clinical Trials Major Product Offerings
7.2.4 LabCorp Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.2.5 LabCorp Key News & Latest Developments
7.3 Charles River
7.3.1 Charles River Company Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Infectious Disease Clinical Trials Major Product Offerings
7.3.4 Charles River Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.3.5 Charles River Key News & Latest Developments
7.4 WuXi AppTec
7.4.1 WuXi AppTec Company Summary
7.4.2 WuXi AppTec Business Overview
7.4.3 WuXi AppTec Infectious Disease Clinical Trials Major Product Offerings
7.4.4 WuXi AppTec Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.4.5 WuXi AppTec Key News & Latest Developments
7.5 Syneos Health
7.5.1 Syneos Health Company Summary
7.5.2 Syneos Health Business Overview
7.5.3 Syneos Health Infectious Disease Clinical Trials Major Product Offerings
7.5.4 Syneos Health Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.5.5 Syneos Health Key News & Latest Developments
7.6 PPD
7.6.1 PPD Company Summary
7.6.2 PPD Business Overview
7.6.3 PPD Infectious Disease Clinical Trials Major Product Offerings
7.6.4 PPD Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.6.5 PPD Key News & Latest Developments
7.7 ICON Plc
7.7.1 ICON Plc Company Summary
7.7.2 ICON Plc Business Overview
7.7.3 ICON Plc Infectious Disease Clinical Trials Major Product Offerings
7.7.4 ICON Plc Infectious Disease Clinical Trials Revenue in Global Market (2018-2023)
7.7.5 ICON Plc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Infectious Disease Clinical Trials Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Clinical Trials Market Drivers in Global Market
Table 3. Infectious Disease Clinical Trials Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Clinical Trials in Global Market
Table 5. Top Infectious Disease Clinical Trials Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Infectious Disease Clinical Trials Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Infectious Disease Clinical Trials Revenue Share by Companies, 2018-2023
Table 8. Global Companies Infectious Disease Clinical Trials Product Type
Table 9. List of Global Tier 1 Infectious Disease Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Infectious Disease Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Infectious Disease Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Infectious Disease Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Infectious Disease Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Infectious Disease Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Infectious Disease Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Infectious Disease Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Infectious Disease Clinical Trials Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Infectious Disease Clinical Trials Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Infectious Disease Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Infectious Disease Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Infectious Disease Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Infectious Disease Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Infectious Disease Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 30. IQVIA Company Summary
Table 31. IQVIA Infectious Disease Clinical Trials Product Offerings
Table 32. IQVIA Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 33. IQVIA Key News & Latest Developments
Table 34. LabCorp Company Summary
Table 35. LabCorp Infectious Disease Clinical Trials Product Offerings
Table 36. LabCorp Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 37. LabCorp Key News & Latest Developments
Table 38. Charles River Company Summary
Table 39. Charles River Infectious Disease Clinical Trials Product Offerings
Table 40. Charles River Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Key News & Latest Developments
Table 42. WuXi AppTec Company Summary
Table 43. WuXi AppTec Infectious Disease Clinical Trials Product Offerings
Table 44. WuXi AppTec Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 45. WuXi AppTec Key News & Latest Developments
Table 46. Syneos Health Company Summary
Table 47. Syneos Health Infectious Disease Clinical Trials Product Offerings
Table 48. Syneos Health Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 49. Syneos Health Key News & Latest Developments
Table 50. PPD Company Summary
Table 51. PPD Infectious Disease Clinical Trials Product Offerings
Table 52. PPD Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 53. PPD Key News & Latest Developments
Table 54. ICON Plc Company Summary
Table 55. ICON Plc Infectious Disease Clinical Trials Product Offerings
Table 56. ICON Plc Infectious Disease Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 57. ICON Plc Key News & Latest Developments
List of Figures
Figure 1. Infectious Disease Clinical Trials Segment by Type in 2022
Figure 2. Infectious Disease Clinical Trials Segment by Application in 2022
Figure 3. Global Infectious Disease Clinical Trials Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Clinical Trials Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Infectious Disease Clinical Trials Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Clinical Trials Revenue in 2022
Figure 8. By Type - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 9. By Application - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 10. By Type - Global Infectious Disease Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 12. By Application - Global Infectious Disease Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 14. By Region - Global Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 15. By Country - North America Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 16. US Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 20. Germany Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 21. France Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 28. China Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 32. India Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 34. Brazil Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Infectious Disease Clinical Trials Revenue Market Share, 2018-2029
Figure 37. Turkey Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Infectious Disease Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 41. IQVIA Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. LabCorp Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. WuXi AppTec Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Syneos Health Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. PPD Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ICON Plc Infectious Disease Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
